Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  dronabinol
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-12 of 12 for your search:
Start Over
Phase III Compazine vs Methadone vs Tetrahydrocannabinol vs Placebo in Patients Receiving ADR for Malignant Neoplasms
Phase: Phase III, Phase II
Type: Supportive care
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MAYO-818304, NCCTG-818304, NCI-W82-1092, W82-1092
Phase III Randomized, Double-Blind Study of Megestrol vs Dronabinol vs Both in Patients with Cancer-Related Anorexia and Cachexia
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCCTG-959255, NCI-P96-0075
Phase III Antiemetic Therapy with Intramuscular Levonantradol vs Oral Tetrahydrocannabinol for Patients Receiving Antineoplastic Chemotherapy
Phase: Phase III
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: UMCC-8135
Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer
Phase: Phase III
Type: Supportive care, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 2006-0841, MDA-2006-0841, CDR0000573510, NCI-2009-00637, NCT00553059
Randomized Double-Blind Comparison of Metoclopramide vs Tetrahydrocannabinol to Control CACP-Induced Vomiting
Phase: Phase II, Phase I
Type: Supportive care
Status: Closed
Age: 18 and over
Sponsor:
Protocol IDs: MSKCC-8127
Phase II Oral vs Rectal Tetrahydrocannabinol in the Treatment of CACP-Induced Nausea and Vomiting
Phase: Phase II
Type: Supportive care
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCI-D81-043-517, MDA-PC-8101
Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study
Phase: Phase II
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: PS-8-0008, NCT00316563
A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas
Phase: Phase I
Type: Supportive care
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Pro00007559, 7136-05-6R0, NCT00314808
Randomized Double-Blind Comparison of Tetrahydrocannabinol vs Haloperidol as Antiemetics for Cancer Patients Receiving Chemotherapy
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 16 and over
Sponsor:
Protocol IDs: NCI-D79-035-229, OSU-79HO156
Effect of Dosage Level on Antiemetic Properties of Tetrahydrocannabinol in Cancer Patients with Chemotherapy-Induced Nausea and Vomiting
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: over 18
Sponsor:
Protocol IDs: NCI-D81-014-437
Antiemetic Therapy with THC for Patients Undergoing Chemotherapy for Cancer
Phase: No phase specified
Type: Supportive care
Status: Closed
Age: 21 to 65
Sponsor:
Protocol IDs: UMCC-7903
Randomized Comparison of Droperidol vs Tetrahydrocannabinol as Anti-Emetics in Patients with Gynecologic Malignancies Treated with CACP
Phase: No phase specified
Type: Supportive care
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: GOG-51
Start Over